Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Le Poole

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The American Journal of Pathology|November 7, 2009
Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cellsJared Klarquist, Allison Barfuss, Sridhar Kandala, et al.
The American Journal of Pathology|May 14, 2013
Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosisEmily R Gilbert, Jonathan M Eby, Adam M Hammer, et al.
Molecular Cancer Research : MCR|December 27, 2022
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint InhibitorsSarah E Fenton, Markella Zannikou, Liliana Ilut, et al.
Cancer Research|September 17, 2016
Ccl22 Diverts T Regulatory Cells and Controls the Growth of MelanomaJared Klarquist, Kristen Tobin, Peyman Farhangi Oskuei, et al.
The Journal of Investigative Dermatology|January 2, 2025
Bacillus Subtilis-Derived Exopolysaccharide Halts Depigmentation and Autoimmunity in VitiligoAhmed A Touni, Sara Muttar, Zoya Siddiqui, et al.
NPJ Regenerative Medicine|December 5, 2024
Attenuation of skin injury by a MARCO targeting PLGA nanoparticleUmmiye V Onay, Dan Xu, Dauren Biyashev, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 9, 2023
Skin Infiltrate Composition as a Telling Measure of Responses to Checkpoint InhibitorsCory Kosche, Dinesh Jaishankar, Cormac Cosgrove, et al.
Frontiers in Immunology|December 18, 2020
Antigen Specificity Enhances Disease Control by Tregs in VitiligoZhussipbek Mukhatayev, Emilia R Dellacecca, Cormac Cosgrove, et al.
Cancers|February 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and BeyondSurya Pandey, Meghan E Cholak, Rishita Yadali, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The American Journal of Pathology|November 7, 2009
Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cellsJared Klarquist, Allison Barfuss, Sridhar Kandala, et al.
The American Journal of Pathology|May 14, 2013
Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosisEmily R Gilbert, Jonathan M Eby, Adam M Hammer, et al.
Molecular Cancer Research : MCR|December 27, 2022
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint InhibitorsSarah E Fenton, Markella Zannikou, Liliana Ilut, et al.
Cancer Research|September 17, 2016
Ccl22 Diverts T Regulatory Cells and Controls the Growth of MelanomaJared Klarquist, Kristen Tobin, Peyman Farhangi Oskuei, et al.
The Journal of Investigative Dermatology|January 2, 2025
Bacillus Subtilis-Derived Exopolysaccharide Halts Depigmentation and Autoimmunity in VitiligoAhmed A Touni, Sara Muttar, Zoya Siddiqui, et al.
NPJ Regenerative Medicine|December 5, 2024
Attenuation of skin injury by a MARCO targeting PLGA nanoparticleUmmiye V Onay, Dan Xu, Dauren Biyashev, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 9, 2023
Skin Infiltrate Composition as a Telling Measure of Responses to Checkpoint InhibitorsCory Kosche, Dinesh Jaishankar, Cormac Cosgrove, et al.
Frontiers in Immunology|December 18, 2020
Antigen Specificity Enhances Disease Control by Tregs in VitiligoZhussipbek Mukhatayev, Emilia R Dellacecca, Cormac Cosgrove, et al.
Cancers|February 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and BeyondSurya Pandey, Meghan E Cholak, Rishita Yadali, et al.
Pageof 8